Low-dose <i>i</i> nterleukin 2 for the reduction of <i>v</i> ascular inflammati <i>o</i> n in acute corona <i>ry</i> syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial - Concepedia

Concepedia

Publication | Open Access

Low-dose <i>i</i> nterleukin 2 for the reduction of <i>v</i> ascular inflammati <i>o</i> n in acute corona <i>ry</i> syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial

DOI Full Paper Access

38

Citations

36

References

2022

Year

Rouchelle Sriranjan, Tian Zhao, Jason M. Tarkin, Annette Hubsch, Joanna Helmy, Evangelia Vamvaka, Navazh Jalaludeen, Simon Bond, Stephen P. Hoole, Philip Knott,

Abstract

NCT04241601.

References

	Year	Citations

Page 1